My Quote Request
6505-01-260-0904
20 Products
NDC00054-4859-29
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012600904
NSN
6505-01-260-0904
NDC00054-4859-29
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012600904
NSN
6505-01-260-0904
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 MILLIGRAMS TRIAZOLAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAZOLAM TABLETS USP 0.25MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: CLASS 4
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,UPJOHN
Related Searches:
NDC00009-0017-02
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012600904
NSN
6505-01-260-0904
NDC00009-0017-02
TRIAZOLAM TABLETS,USP
NSN, MFG P/N
6505012600904
NSN
6505-01-260-0904
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 MILLIGRAMS TRIAZOLAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAZOLAM TABLETS USP 0.25MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: CLASS 4
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,UPJOHN
Related Searches:
NDC00054-4498-10
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012601153
NSN
6505-01-260-1153
NDC00054-4498-10
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012601153
NSN
6505-01-260-1153
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS LEUCOVORIN CALCIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEUCOVORIN CALCIUM TABLETS 15MG 24S BT
PRIMARY CONTAINER CONTENT QUANTITY: 24.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, LEDERLE LABORATORIES
Related Searches:
NDC58406-0626-74
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012601153
NSN
6505-01-260-1153
NDC58406-0626-74
LEUCOVORIN CALCIUM TABLETS
NSN, MFG P/N
6505012601153
NSN
6505-01-260-1153
MFG
AMGEN INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS LEUCOVORIN CALCIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEUCOVORIN CALCIUM TABLETS 15MG 24S BT
PRIMARY CONTAINER CONTENT QUANTITY: 24.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, LEDERLE LABORATORIES
Related Searches:
NDC00182-1174-01
METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012601236
NSN
6505-01-260-1236
NDC00182-1174-01
METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012601236
NSN
6505-01-260-1236
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GOLDLINE LABS
Related Searches:
NDC00406-1124-01
METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012601236
NSN
6505-01-260-1236
NDC00406-1124-01
METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012601236
NSN
6505-01-260-1236
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GOLDLINE LABS
Related Searches:
NDC53014-0532-07
METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012601236
NSN
6505-01-260-1236
NDC53014-0532-07
METHYLPHENIDATE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012601236
NSN
6505-01-260-1236
MFG
MIDWEST MEDICAL SUPPLY CO L L C DBA MMS A MEDICAL SUPPLY COMPANY DIV GOVERNMENT SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METHYLPHENIDATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPHENIDATE HYDROCHLORIDE TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GOLDLINE LABS
Related Searches:
7100-13
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601237
NSN
6505-01-260-1237
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 5% 50ML PLASTIC BAG 50S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 100 ML,LEAK-PROOF; ONE PERMANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES AS
TOTAL PRIMARY CONTAINER QUANTITY: 50
~1: WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLIMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185-51
~2: 58,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,6515-01-153-5669
Related Searches:
7100-13-75
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601237
NSN
6505-01-260-1237
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 5% 50ML PLASTIC BAG 50S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 100 ML,LEAK-PROOF; ONE PERMANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES AS
TOTAL PRIMARY CONTAINER QUANTITY: 50
~1: WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLIMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185-51
~2: 58,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,6515-01-153-5669
Related Searches:
NDC00074-7100-13
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601237
NSN
6505-01-260-1237
NDC00074-7100-13
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601237
NSN
6505-01-260-1237
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 5% 50ML PLASTIC BAG 50S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 100 ML,LEAK-PROOF; ONE PERMANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES AS
TOTAL PRIMARY CONTAINER QUANTITY: 50
~1: WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLIMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185-51
~2: 58,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,6515-01-153-5669
Related Searches:
NDC00074-7100-66
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601237
NSN
6505-01-260-1237
NDC00074-7100-66
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601237
NSN
6505-01-260-1237
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 5% 50ML PLASTIC BAG 50S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 100 ML,LEAK-PROOF; ONE PERMANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES AS
TOTAL PRIMARY CONTAINER QUANTITY: 50
~1: WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLIMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185-51
~2: 58,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,6515-01-153-5669
Related Searches:
ADD-VANTAGE D5W
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601239
NSN
6505-01-260-1239
ADD-VANTAGE D5W
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601239
NSN
6505-01-260-1239
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DESTROSE INJECTION USP 5% 250ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; OVERPOUCH BAG; NOT LESS THAN 300 ML CAPACITY; LEAK-PROOF; ONE PERANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETRICALLY SEALED STERILITY PROTECTOR W/RING FOR
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: INTERLOCKING A COMPLEMENTARY GLASS SMALL VOLUME PARENTERAL DRUG VIAL; COMPATIBLE W/INTRAVENOUS INJECTION SETS 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703 AND 6515-01-153-5669
Related Searches:
NDC00074-7100-02
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601239
NSN
6505-01-260-1239
NDC00074-7100-02
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012601239
NSN
6505-01-260-1239
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DESTROSE INJECTION USP 5% 250ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE; OVERPOUCH BAG; NOT LESS THAN 300 ML CAPACITY; LEAK-PROOF; ONE PERANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETRICALLY SEALED STERILITY PROTECTOR W/RING FOR
TOTAL PRIMARY CONTAINER QUANTITY: 24
~1: INTERLOCKING A COMPLEMENTARY GLASS SMALL VOLUME PARENTERAL DRUG VIAL; COMPATIBLE W/INTRAVENOUS INJECTION SETS 6515-00-115-0032,6515-00-140-0888,6515-00-185-5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703 AND 6515-01-153-5669
Related Searches:
ADD-VANTAGE NS
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601241
NSN
6505-01-260-1241
ADD-VANTAGE NS
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601241
NSN
6505-01-260-1241
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 50ML PLASTIC BAG 48S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 100 ML,LEAK-PROOF; ONE PER MANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES
TOTAL PRIMARY CONTAINER QUANTITY: 48
~1: AS WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLIMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185
~2: -5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
Related Searches:
NDC00074-7101-13
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601241
NSN
6505-01-260-1241
NDC00074-7101-13
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601241
NSN
6505-01-260-1241
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 50ML PLASTIC BAG 48S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 100 ML,LEAK-PROOF; ONE PER MANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES
TOTAL PRIMARY CONTAINER QUANTITY: 48
~1: AS WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLIMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185
~2: -5158,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
Related Searches:
7101-23-77
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601242
NSN
6505-01-260-1242
7101-23-77
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601242
NSN
6505-01-260-1242
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 100ML PLASTIC BAG 48S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 150 ML,LEAK-PROOF; ONE PERMANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES AS
TOTAL PRIMARY CONTAINER QUANTITY: 48
~1: WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLEMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185-51
~2: 58,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
Related Searches:
NDC00074-7101-23
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601242
NSN
6505-01-260-1242
NDC00074-7101-23
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012601242
NSN
6505-01-260-1242
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 100ML PLASTIC BAG 48S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: SINGLE DOSE,CAPACITY OF NOT LESS THAN 150 ML,LEAK-PROOF; ONE PERMANENTLY ATTACHED OUTLET PORT FORCE-FITTED W/STERILITY PROTECTOR W/TAB; ONE PERMANENTLY ATTACHED TAMPER RESISTANT INLET PORT W/HERMETICALLY SEALED STERILITY PROTECTOR W/RING; A TRAY SERVES AS
TOTAL PRIMARY CONTAINER QUANTITY: 48
~1: WATER VAPOR BARRIER FOR 4 BAGS,12 OVERPOUCHED TRAYS OF 4 BAGS PER PACKAGE; WITH COMPLEMENTARY GLASS SMALL VOLUME PARENTERAL VIALS; COMPATIBLE W/INTRAVENOUS INJECTION SETS,6515-00-115-0032,6515-00-140-0888,6515-00-185-51
~2: 58,6515-00-484-0484,6515-01-082-1021,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
Related Searches:
03023
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505012602515
NSN
6505-01-260-2515
03023
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505012602515
NSN
6505-01-260-2515
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC39769-0042-02
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505012602515
NSN
6505-01-260-2515
NDC39769-0042-02
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505012602515
NSN
6505-01-260-2515
MFG
SOLOPAK MEDICAL PRODUCTS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
6560
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505012604977
NSN
6505-01-260-4977
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS METRONIDAZOLE PER MILLILITER
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 12